Closure of Trading Window from 1st April 2026 till 48 hours after the end of the Board Meeting wherein, Approval of Audited Financial Results for the quarter and year ended 31st March,2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has informed BSE that the trading window for dealing in its securities will remain closed from April 1, 2026, until 48 hours after the end of the upcoming Board Meeting. The Board Meeting will consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026. This closure applies to all designated persons and their immediate relatives under SEBI's Insider Trading Regulations. The intimation was signed by Managing Director Fredun Nariman Medhora on March 26, 2026. This is a routine compliance disclosure with no actual insider trading or share movement involved.
No direct impact on shareholders or stock price — this is a standard regulatory filing. Investors should watch for the upcoming audited FY26 results announcement, which could move the stock depending on the numbers.